These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7721030)

  • 1. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Furukawa S; Hayashi K; Hirata H; Tanaka S; Tomita K
    Gen Pharmacol; 1994 Dec; 25(8):1567-75. PubMed ID: 7721030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
    J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
    Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
    Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S
    Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
    Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
    Takeda M; Shou I; Tomino Y
    Gen Pharmacol; 1998 May; 30(5):749-52. PubMed ID: 9559329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats.
    Yokoyama T; Masuda Y; Sakai T; Tanaka S; Tomita K
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):851-6. PubMed ID: 1376803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of efonidipine hydrochloride, calcium antagonist on the epithelium of prostates in spontaneously hypertensive rats.
    Furukawa S; Yamamoto O; Tamura T; Masuda Y; Shudo C; Hayashi K; Hirata H
    J Toxicol Sci; 1994 Nov; 19(4):213-7. PubMed ID: 7884832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M; Ogawa T; Han WH; Takabatake T
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of efonidipine hydrochloride on renal arteriolar diameters in spontaneously hypertensive rats.
    Nakamura M; Notoya M; Kohda Y; Yamashita J; Takashita Y; Gemba M
    Hypertens Res; 2002 Sep; 25(5):751-5. PubMed ID: 12452329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
    Watanabe S; Ono H; Ishimitsu T; Matsuoka H; Ono Y; Fujimori T
    Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of efonidipine hydrochloride (NZ-105), a new calcium antagonist, against acute renal failure in rats.
    Shudo C; Masuda Y; Sugita H; Tanaka S; Tomita K
    Gen Pharmacol; 1994 Nov; 25(7):1451-8. PubMed ID: 7896060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antihypertensive drug nifedipine on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
    Kaneko S; Takizawa H; Takeda M; Shou I; Tomino Y
    Gen Pharmacol; 1999 Nov; 33(5):363-7. PubMed ID: 10553876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the hypotensive mechanisms of NZ-105, a new dihydropyridine derivative, in rats and rabbits.
    Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1993 Mar; 24(2):411-8. PubMed ID: 8482525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polyphenol-containing azuki bean (Vigna angularis) extract on blood pressure elevation and macrophage infiltration in the heart and kidney of spontaneously hypertensive rats.
    Sato S; Mukai Y; Yamate J; Kato J; Kurasaki M; Hatai A; Sagai M
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):43-9. PubMed ID: 18047626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.
    Fan YY; Kohno M; Nakano D; Ohsaki H; Kobori H; Suwarni D; Ohashi N; Hitomi H; Asanuma K; Noma T; Tomino Y; Fujita T; Nishiyama A
    J Hypertens; 2010 May; 28(5):1034-43. PubMed ID: 20411599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.